Prosecution Insights
Last updated: August 18, 2026

Examiner: HAGHIGHATIAN, MINA

Tech Center 1600 • Art Units: 1616 1626

This examiner grants 46% of resolved cases

Performance Statistics

45.8%
Allow Rate
-14.2% vs TC avg
924
Total Applications
+39.7%
Interview Lift
1183
Avg Prosecution Days
Based on 875 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
8.9%
§102 Novelty
39.4%
§103 Obviousness
25.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18721774 USE OF BISMUTH OXYCARBONATE PARTICLES FOR FILTERING ULTRAVIOLET RADIATION Non-Final OA L'OREAL
18932725 TISSUE-DERIVED IMPLANT USEFUL FOR CARTILAGE REGENERATION Non-Final OA Peking University Third Hospital
17262421 Dry Powder Formulations for Messenger RNA Non-Final OA Translate Bio, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month